newsThe FDA has approved Crysvita, the first drug approved to…
20 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...